<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v2i4.410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Observation of Stereotactic Radiosurgery (Cyberknife) on Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis</title><url>https://artdesignp.com/journal/JCNR/2/4/10.26689/jcnr.v2i4.410</url><author>TangYang</author><pub-date pub-type="publication-year"><year>2018</year></pub-date><volume>2</volume><issue>4</issue><history><date date-type="pub"><published-time>2018-10-12</published-time></date></history><abstract>The purpose of the study was to analyze the clinical effect of stereotactic radiosurgery (SRS) (Cyberknife) on hepatocellular carcinoma with portal vein tumor thrombosis (HCC-PVTT). Data from 50 patients with HCC-PVTT who received Cyberknife from August 2013 to April 2016 was collected for efficacy analysis. Moreover, survival correlation was evaluated by Cox proportionalhazards model. The total effective rate in 1â€“3 months after treatment was 64.00%, including 7 cases in complete remission, 12 cases in partial remission, 13 cases in stable conditions, and 18 cases with enlargement; a 4â€“24-months follow-up (with an average of 11.58 Â± 2.58 months) showed that median survival, 1-year cumulative survival rate, and 2-year cumulative survival rate were, respectively, 11.86 Â± 1.79 months, 48.00%, and 20.00%. Moreover, the Cox proportional-hazards model indicates that it was with no correlation between lesion diameter, classification of liver function, pre-operative alphafetoprotein,Â types of hepatitis, number of tumors, ascites, types of tumor emboli, total dose, and survival rate. SRS is effective for HCC-PVTT and serves as an ideal treatment clinically to help preserve patientsâ€™ lives, which is worthy of clinical promotion and application.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Liyu, Liu Xiaoliang, Zhang Sujing, et.al. Observation of Stereotactic Radiosurgery (SRS) on 30 cases of advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (HCC-PVTT) [C]// Clinical Seminar by Chinese Journal of Histochemistry and Cytochemistry. 2017,25(2):25-26.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Wan Zhiqing, Duan Xuezhang. Efficacy and Safety of Stereotactic Radiotherapy for Primary Liver Cancer [J]. Eletronic Journal of Liver Tumor, 2016, 3(3):7-12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Zhang Tao, Sunjing, He Weiping, et. al. Efficacy of Stereotactic Radiosurgery for Small Hepatocellular Carcinoma [J]. Journal of Clinical Hepatology, 2017, 33(4):694-698.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Cheng Tao. Observation of Stereotactic Radiosurgery (SRS) on Small Hepatocellular Carcinoma [J]. Journal of Imaging Research and Medical Applications, 017, 1(10):41-42.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Xu Ruisha, Yu Shuyong, Xu Xiaojiang, et.al. Efficacy of Stereotactic Radiotherapy with Cyberknife for the Treatment of Liver Metastases from Colorectal Cancer [J]. Progress in Modern Biomedicine, 2017, 17(4):684-687.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Li Huan, Sun Jing, Zhang Tao et.al. Efficacy and Prognosis of Cyberknife in Treatment of Recurrent Hepatocellular Carcinoma [J]. Journal of Clinical Hepatology, 2017,14(12):2337-2341.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Li Yu, Zhang Sujing, Liu Xiaoliang et.al. Observation of Stereotactic Radiotherapy for 50 Cases of Early Primary Liver Cancer [J]. Journal of Chinese Oncology, 2016, 22(1):49-52.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Gao Yunhong, Wang Mancang, Zhang Yiping. Preliminary Analysis of Cyberknife efficacy in Ttreatment of Primary Lung Cancer [J]. China Continuing Medical Education, 2016, 8(12):64-65.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
